Single-Use Negative Pressure Wound Therapy Devices Market is expected to reach US$ 892.32 million by 2028

by Sameer Joshi or 09-Apr-2021
Growing Research Activities to Drive Single-Use Negative Pressure Wound Therapy Devices Market During 2021–2028
 
According to a new market research study titled “Single-Use Negative Pressure Wound Therapy Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Wound Type and End User,” the market is expected to reach US$ 892.32 million by 2028 from US$ 462.05 million in 2020. It is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights the trends prevalent in the market and the factors driving the market along with those that act as restraints to its growth. Rising incidence of chronic diseases and increasing cases of burn injuries are driving the market. However, the market is expected to have slower growth rate due to the lack of effective reimbursement policies for wound care.
 
Chronic-wound management products are essential in the healthcare sector. The research activities carried out in the last few years have resulted in the availability of innovative products and solutions in the wound management sector. For instance, in February 2017, Centurion launched a new wound irrigation system, IRIG-8, for acute wound management in emergency rooms. As per a study published in the American Journal of Emergency Medicine regarding lab-simulated wounds, the IRIG-8 Wound Irrigation System resulted in ~14.0% decrease in bacterial load, whereas the use of a syringe with a splash guard led to the increase in bacterial pressure by up to 11.5%. The launch of more such innovative and effective products is expected to fuel the single-use negative pressure wound therapy devices market during the forecast period.    
 
Prominent players operating in the single-use negative pressure wound therapy devices market include Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc. 
 
The report segments the global single-use negative pressure wound therapy devices market as follows:

By Wound Type
  • Surgical
  • Traumatic
  • Diabetic Foot
  • Sports Injuries
  • Venous Leg Ulcers
  • Others
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com